Funder
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre
Subject
General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology
Reference22 articles.
1. AHJ K , Sparks JA , Liew JW , et al . A rush to judgment? rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for COVID-19. Ann Intern Med 2020:M20–1223.
2. Lane JCE , Weaver J , Kostka K , et al . Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study. Rheumatology 2020.
3. Considerations for drug interactions on QTc in exploratory COVID-19 (coronavirus disease 2019) treatment;Roden;J Am Coll Cardiol,2020
4. Chorin E , Dai M , Shulman E , et al . The QT interval in patients with SARS-CoV-2 infection treated with Hydroxychloroquine/Azithromycin. Cardiovascular Medicine 2020.
5. Chen Z , Hu J , Zhang Z , et al . Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial. Epidemiology 2020.
Cited by
69 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献